DENTSPLY SIRONA Inc. XRAY
Nasdaq · XNAS · stock · Dental Equipment & Supplies
Chart by TradingView
6/9
Piotroski F — financial health
-0.3
Altman Z″ — distress risk · distress
-21.4%
Dividend payout · safe
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $3.7B | -$598.0M | $1.8B | — | $1.3B |
| 2024 | $3.8B | -$910.0M | $2.0B | — | $1.9B |
| 2023 | $4.0B | -$132.0M | $2.1B | — | $3.3B |
| 2022 | $3.9B | -$950.0M | $2.1B | $368.0M | $3.8B |
| 2021 | $4.2B | $411.0M | $2.3B | $515.0M | $5.0B |
| 2020 | $3.3B | -$73.0M | $1.7B | $562.0M | $4.9B |
Why these scores methodology →
Piotroski F-score: 6/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -0.3 (distress)
- Working capital / assets 0.125
- Retained earnings / assets -0.288
- EBIT / assets -0.078
- Equity / liabilities 0.328
Source: SEC EDGAR filings · CIK 0000818479 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.